Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[18F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET-Reference-Cited by-同舟云学术

Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[18F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET

Published:2015-06-22 Issue:8 Volume:58 Page:349-354
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J. Label Compd. Radiopharm

Author:

Mou Tiantian¹²,Zhao Zuoquan³,You Linyi¹,Wang Qian²,Fang Wei³,Lu Jie⁴,Peng Cheng⁵,Zhang Xianzhong¹

Affiliation:

1. Center for Molecular Imaging and Translational Medicine, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health; Xiamen University; Xiamen 361005 China

2. Department of Nuclear Medicine, Beijing Anzhen Hospital; Capital Medical University; Beijing 100029 China

3. Department of Nuclear Medicine, Cardiovascular Institute and Fu Wai Hospital; Chinese Academy of Medical Sciences; Beijing 100037 China

4. Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry; Beijing Normal University; Beijing 100875 China

5. PET Center; Xuanwu Hospital of Capital University of Medical Sciences; Beijing 100053 China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Reference25 articles.

1. EANM/ESC guidelines for radionuclide imaging of cardiac function;Hesse;Eur. J. Nucl. Med. Mol. Imaging,2008

2. Present and future of clinical cardiovascular PET imaging in Europe-a position statement by the European Council of Nuclear Cardiology (ECNC);Guludec;Eur. J. Nucl. Med. Mol. Imaging,2008

3. Characterization of Uptake of the New PET Imaging Compound 18 F-Fluorobenzyl Triphenyl Phosphonium in Dog Myocardium;Madar;J. Nucl. Med.,2006

4. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin;Madar;J. Nucl. Med.,2007

5. Synthesis of fluorine-18 labeled rhodamine B: a potential PET myocardial perfusion imaging agent;Heinrich;Appl. Radiat. Isot.,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest;Journal of Nuclear Cardiology;2024-04

2. China’s radiopharmaceuticals on expressway: 2014–2021;Radiochimica Acta;2022-04-21

3. Synthesis and Evaluation of 18F-labeled Pyridaben Analogues for Myocardial Perfusion Imaging in Mice, Rats and Chinese mini-swine;Scientific Reports;2016-09-20

4. Phosphonium salts and P-ylides;Organophosphorus Chemistry